BerGenBio’s management team is composed of experienced biopharma executives with a drive for creating novel therapeutics for cancer. The Company’s management combine a wealth of talent and international experience in drug discovery, AXL cancer biology, and commercialisation.
Management Team
Richard Godfrey (MPharmS, MBA)
Chief Executive Officer
Richard Godfrey joined BerGenBio as Chief Executive Officer in 2008.…
Read More
Anthony Brown (PhD, MBA)
Chief Scientific Officer
Dr Anthony Brown joined BerGenBio as Research Director in October…
Read More
Alan Barge (MD)
Interim Chief Medical Officer
Dr Alan Barge joined BerGenBio in 2018 and serves as…
Read More
Tone Bjaaland (PhD)
Director of Clinical Operations
Tone Bjaaland joined BerGenBio in 2018 and serves as Director…
Read More
Endre Kjærland (PhD)
Associate Director of IP and Contracts
Dr Endre Kjærland joined BerGenBio AS in 2011 and is…
Read More
Julia Schölermann (PhD, MBA)
Director BD & Partnering
Dr Julia Schoelermann joined BerGenBio in 2015. She is responsible…
Read More
Prof James Lorens
Senior Scientific Advisor
Professor James Lorens is the co-founder of BerGenBio, serves as…
Read More
Jonas Lies vei 91, 5009 Bergen, Norway
+ 47 559 61 159 (general) + 47 535 01 564 (urgent medical enquiries)